Short-course chemotherapy. The Arkansas experience.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001131:Arkansas; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002986:Clinical Trials as Topic; D004342:Drug Hypersensitivity / Q000209:etiology; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000401:mortality
D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin